UK

Corrigendum

Information

Published

External Reference: 2024-590900

FTS Reference: 2024-024409

Corrigendum

Corrigendum

Notice for changes or additional information

Supplies

Section I: Contracting authority/entity

I.1)

Name and addresses

Nottingham Trent University (NTU)
GB 277399933
50 Shakespeare Street
Nottingham
NG1 4FQ
UK
Contact person: Mark Lucas
Telephone: +44 1158488747
E-mail: mark.lucas@ntu.ac.uk
NUTS code:  UKF14 -  Nottingham
Internet address(es):
Main address: https://www.ntu.ac.uk/
Address of the buyer profile: https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/128806

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

Clinical Trial Manufacturing and Distribution Services
Reference number:  NTU/24/2615T/ML
II.1.2)

Main CPV code

33600000  -  Pharmaceutical products
II.1.3)

Type of contract

Supplies
II.1.4)

Short description

Nottingham Trent University requires Clinical Trial Manufacturing and Distribution Services for manufacturing and distribution of fluoxetine (20mg) and a matching placebo.

Section VI: Complementary information

VI.6)

Original notice reference

Notice number in the FTS: 2024/S 000-024231

Section VII: Changes

VII.1)

Information to be changed or added

VII.1.2)

Text to be corrected in the original notice

Section number:  1.5
Place of text to be modified:  Section IV: Procedure
Instead of:  
Read:  
Nottingham Trent University reserves the right to award the contract on the basis of the initial tenders without conducting negotiations.
VII.2)

Other additional information

Nottingham Trent University reserves the right to award the contract on the basis of the initial tenders without conducting negotiations.